...
首页> 外文期刊>Therapeutic delivery >Discussion of prevalence and management of discomfort when swallowing pills: orodispersible tablets expand treatment options in patients with depression
【24h】

Discussion of prevalence and management of discomfort when swallowing pills: orodispersible tablets expand treatment options in patients with depression

机译:吞服药丸时的不适感和患病率的讨论:口服分散片可扩大抑郁症患者的治疗选择

获取原文
获取原文并翻译 | 示例
           

摘要

Many patients experience discomfort when trying to swallow tablets and capsules, but this issue is rarely discussed between patients and physicians. Discomfort when swallowing pills is common and arises due to the morphology of the oropharynx and esophagus, which are not well suited to swallowing rigid objects of small volume. Compliance with medication is poor in patients with chronic diseases such as depression. An inability or unwillingness to swallow medication can further reduce acceptance of and compliance with medication, which has an impact on effectiveness. Recognition that patient acceptance of prescribed medication is an important component of compliance has led to the development of pill-swallowing training programs and alternative formulations. Orodispersible tablets do not need to be taken with water and can be packaged discreetly in single doses. Orodispersible tablets have been shown to be effective in a number of therapy areas including depression.
机译:许多患者在尝试吞咽片剂和胶囊剂时会感到不适,但是这个问题很少在患者和医生之间讨论。吞咽药丸时通常会感到不适,这是由于口咽和食道的形态引起的,不适用于吞咽小体积的硬物。患有慢性疾病(例如抑郁症)的患者对药物的依从性较差。不能吞咽药物或不愿意吞咽药物会进一步降低药物的接受程度和依从性,从而影响疗效。认识到患者对处方药的接受是依从性的重要组成部分,这导致了吞丸训练方案和替代制剂的发展。口腔分散片剂无需用水服用,可以单剂量谨慎包装。口分散片已显示在包括抑郁症在内的许多治疗领域有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号